#0191 We found that in a large South London RA cohort, use of advanced therapy in moderate disease (DAS28 3.2-5.1) […]

Real-world T2T strategy from MONITOR-PsA cohort: 🎯 At 48 weeks – 33.6% (49/146) of pts achieved PASDAS ‘moderate’ res https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg

Albach et al. CAR T-cells in D2T RA. 6 patients. Safety looks ok. ACR20 in 4/6, ACR50 in 2/6. ACPA

SELECT-GCA (upadacitinib in GCA for 52w) we hoped it might have ongoing effect post-cessation Do we need to continue up

#0776 In the 2-yr SELECT-GCA trial, continued upadacitinib 15mg maintained remission in 69% vs 29% who switched to PBO, https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg

RheumNow’s expanded coverage of the #ACR2025 annual meeting is sponsored by Bristol Myers Squibb, Novartis, and UCB. A https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

Singla et al. In secukinumab phase 3 trials, fungal (inc candida) infections uncommon. 5.51 for sec vs 3.39 for PBO

Schmidt et al. 2 year results of SELECT-GCA, upadacitinib in GCA. Remission 69% if upa continued vs 29% if stopped.

Not all inflammatory nasal lesions are vasculitis! Dr. Zacharek presents from the ENT perspective @RheumNow #ACR25 http https://pbs.twimg.com/profile_images/1684945388665442304/yPWpfGoX_normal.jpg john+RNV2@john… Sun,

SLE Conference Preview: progress in biologics y.yusof@leeds.ac.uk Sun, 10/26/2025 – 14:00

AI-enhanced MRI integrating STIR and T1-weighted MRI with BME data reflecting both inflammatory and structural changes, https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john… Sun, 10/26/2025

Join us at 5pm CST for Day 1 #ACR25 recap! https://t.co/EwZSiPhysF https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun, 10/26/2025 – 11:03 RheumNow Dr. John

Plenary session at #ACR25! #0772 When should we biopsy in SLE? In pts with uPCR 0.25-0.49 g/g + LN predictors,

#LLM can be #virtual #tutor for 👇 #OSCE RCT – better competence &confidence #AI & #medical #education AI https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G_normal.jpg john+RNV2@john…

Early, low level proteinuria is a harbinger in SLE. ~50% with elevated UPCR but <0.5 had actionable LN on early

#Pros and #cons of #AI Need to know both Need to assess AI #quality and #accuracy ‘Assume AI WILL be

What’s new in the Pre-RA world? Slowly unraveling mechanisms and biology associated to transition from CCP+ asymptomati https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john… Sun,

From Dr. Petri at Plenary – even small amounts of proteinuria are a PROBLEM. Reduction of microalbuminuria by even 10%

#AI for medical use is fast moving governance is Impt Protect Privacy Facilitate trainees to LEARN Involve #IT, ethici https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G_normal.jpg

Rheum guidelines balance data & context. Beyond evidence, factors like cost, equity & feasibility shape recs. https://pbs.twimg.com/profile_images/1525262133575012354/Lfut18gD_normal.jpg john+RNV2@john… Sun, 10/26/2025

Sooner May Still Be Too Late: Kidney Biopsies in SLE michael.putman… Sun, 10/26/2025 – 09:02

Sleep Apnea in Psoriatic Arthritis – A Wake Up Call synovialjoints… Sun, 10/26/2025 – 09:01

New pieces added to the Pre-RA puzzle aurelie.najm@g… Sun, 10/26/2025 – 08:45